<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Genetics</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Genetics</journal-title><trans-title-group xml:lang="ru"><trans-title>Генетика</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0016-6758</issn><issn publication-format="electronic">3034-5103</issn><publisher><publisher-name xml:lang="en">The Russian Academy of Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">667203</article-id><article-id pub-id-type="doi">10.31857/S0016675824090094</article-id><article-id pub-id-type="edn">adlqwz</article-id><article-categories><subj-group subj-group-type="toc-heading"><subject>ГЕНЕТИКА ЧЕЛОВЕКА</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Association of long non-coding RNA genes (<italic>H19</italic>, <italic>MEG3</italic>, <italic>MALAT1</italic>, <italic>Linc00305</italic>, <italic>Linc00261</italic>, <italic>Linc02227</italic>, and <italic>CDKN2B-AS1</italic>) polymorphic loci with chronic obstructive pulmonary disease</article-title><trans-title-group xml:lang="ru"><trans-title>Ассоциация полиморфных локусов генов длинных некодирующих РНК (<italic>H19</italic>, <italic>MEG3</italic>, <italic>MALAT1</italic>, <italic>Linc00305</italic>, <italic>Linc00261</italic>, <italic>Linc02227</italic> и <italic>CDKN2B-AS1</italic>) с хронической обструктивной болезнью легких</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Korytina</surname><given-names>G. F.</given-names></name><name xml:lang="ru"><surname>Корытина</surname><given-names>Г. Ф.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>guly_kory@mail.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Akhmadishina</surname><given-names>L. Z.</given-names></name><name xml:lang="ru"><surname>Ахмадишина</surname><given-names>Л. З.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>guly_kory@mail.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Markelov</surname><given-names>V. A.</given-names></name><name xml:lang="ru"><surname>Маркелов</surname><given-names>В. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>guly_kory@mail.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Nasibullin</surname><given-names>T. R.</given-names></name><name xml:lang="ru"><surname>Насибуллин</surname><given-names>Т. Р.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>guly_kory@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Aznabaeva</surname><given-names>Y. G.</given-names></name><name xml:lang="ru"><surname>Азнабаева</surname><given-names>Ю. Г.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>guly_kory@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kochetova</surname><given-names>O. V.</given-names></name><name xml:lang="ru"><surname>Кочетова</surname><given-names>О. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>guly_kory@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Khusnutdinova</surname><given-names>N. N.</given-names></name><name xml:lang="ru"><surname>Хуснутдинова</surname><given-names>Н. Н.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>guly_kory@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Larkina</surname><given-names>A. P.</given-names></name><name xml:lang="ru"><surname>Ларкина</surname><given-names>А. П.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>guly_kory@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zagidullin</surname><given-names>N. S.</given-names></name><name xml:lang="ru"><surname>Загидуллин</surname><given-names>Н. Ш.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>guly_kory@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Victorova</surname><given-names>T. V.</given-names></name><name xml:lang="ru"><surname>Викторова</surname><given-names>Т. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>guly_kory@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Institute of Biochemistry and Genetics - Subdivision of the Ufa Federal Research Centre of the Russian Academy of Sciences</institution></aff><aff><institution xml:lang="ru">Институт биохимии и генетики – обособленное структурное подразделение Уфимского федерального исследовательского центра Российской академии наук</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Bashkir State Medical University</institution></aff><aff><institution xml:lang="ru">Башкирский государственный медицинский университет</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Ufa State Petroleum Technological University</institution></aff><aff><institution xml:lang="ru">Уфимский государственный нефтяной технический университет</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2024-09-10" publication-format="electronic"><day>10</day><month>09</month><year>2024</year></pub-date><volume>60</volume><issue>9</issue><fpage>74</fpage><lpage>89</lpage><history><date date-type="received" iso-8601-date="2025-02-26"><day>26</day><month>02</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Russian Academy of Sciences</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2024, Российская академия наук</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Russian Academy of Sciences</copyright-holder><copyright-holder xml:lang="ru">Российская академия наук</copyright-holder></permissions><self-uri xlink:href="https://transsyst.ru/0016-6758/article/view/667203">https://transsyst.ru/0016-6758/article/view/667203</self-uri><abstract xml:lang="en"><p>Chronic obstructive pulmonary disease (COPD) is a chronic lung disease resulting from dynamic, cumulative gene-environment interactions that cause lung tissue injury, alteration of its normal function and acceleration of cellular senescence. Long non-coding RNAs (lncRNAs) function as critical epigenetic regulators of various aspects of cellular senescence. The objective of the present study is to identify the association between polymorphic variants of <italic>H19</italic> (rs3741219), <italic>MEG3</italic> (rs7158663), <italic>MALAT1 </italic>(rs619586), <italic>LINC00305</italic> (rs2850711), <italic>LINC00261 </italic>(rs6048205), <italic>CDKN2B-AS1</italic> (rs4977574), and <italic>LINC02227</italic> (rs2149954) lncRNAs genes with COPD. DNA samples from COPD patients (<italic>N </italic>= 703) and healthy individuals (<italic>N </italic>= 655) were studied in this study and polymorphic loci were analyzed by real–time PCR. Association with COPD was established with <italic>H19 (</italic>rs3741219), <italic>MEG3 </italic>(rs7158663), <italic>LINC02227</italic> (rs2149954), <italic>MALAT1</italic> (rs619586) and <italic>CDKN2B-AS1</italic> (rs4977574). Polygenic analysis has allowed to identify informative gene-gene combinations that include polymorphic variants of the studied lncRNAs genes and genes encoding molecules of signaling cascades associated with cellular senescence and apoptosis. Multiple regression and ROC-analysis revealed a COPD risk predictive model, which included gene–gene combinations of lncRNAs genes and smoking index (<italic>P </italic>= 4.01 x 10<sup>-48</sup>, AUC = 0.87).</p></abstract><trans-abstract xml:lang="ru"><p>Хроническая обструктивная болезнь легких (ХОБЛ) – это хроническое заболевание, возникающее в результате динамических, кумулятивных ген–средовых взаимодействий, результатом которых является повреждение легочной ткани и изменение ее нормального функционирования, связанное с ускоренным клеточным старением. Длинные некодирующие РНК (днРНК) являются важными эпигенетическими регуляторами различных аспектов клеточного старения. Цель настоящего исследования – выявление ассоциации полиморфных вариантов генов днРНК <italic>H19, MEG3, MALAT1, Linc00305, Linc00261, CDKN2B-AS, Linc02227</italic> с ХОБЛ. В работе были использованы образцы ДНК больных ХОБЛ (<italic>N</italic> = 703) и здоровых индивидов (<italic>N</italic> = 655), полиморфные локусы анализировали методом ПЦР в реальном времени. Ассоциация с развитием ХОБЛ была установлена для генов <italic>H19 </italic>(rs3741219), <italic>MEG3 </italic>(rs7158663), <italic>Linc02227 </italic>(rs2149954), <italic>MALAT1 </italic>(rs619586) и <italic>CDKN2B-AS1 </italic>(rs4977574). Полигенный анализ позволил выявить информативные ген–генные комбинации, включающие полиморфные варианты днРНК и генов, кодирующих компоненты молекулярных каскадов, связанных с клеточным старением и апоптозом. По результатам множественного регрессионного и ROC-анализа получена прогностическая модель формирования ХОБЛ, в которую вошли ген–генные комбинации и индекс курения (<italic>P </italic>= 4.01 x 10<sup>–48</sup>, AUC = 0.87).</p></trans-abstract><kwd-group xml:lang="en"><kwd>Chronic obstructive pulmonary disease</kwd><kwd>long non-coding RNAs</kwd><kwd>cellular senescence</kwd><kwd>polygenic analysis</kwd><kwd>H19</kwd><kwd>MEG3</kwd><kwd>Linc02227</kwd><kwd>CDKN2B-AS1</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>хроническая обструктивная болезнь легких</kwd><kwd>длинные некодирующие РНК</kwd><kwd>клеточное старение</kwd><kwd>полигенный анализ</kwd><kwd>H19</kwd><kwd>MEG3</kwd><kwd>Linc02227</kwd><kwd>CDKN2B-AS1</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution xml:lang="ru">Российский научный фонд</institution></institution-wrap><institution-wrap><institution xml:lang="en">Russian Science Foundation</institution></institution-wrap></funding-source><award-id>23-25-00019</award-id></award-group></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Agustí A., Celli B.R., Criner G.J. et al. Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary // Eur. Respir. J. 2023. V. 61. № 4. P. 2300239. doi: 10.1183/13993003.00239-2023</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Чучалин А.Г., Авдеев С.Н., Айсанов З.Р. и др. Хроническая обструктивная болезнь легких: федеральные клинические рекомендации по диагностике и лечению // Пульмонология. 2022. Т. 32. № 3. С. 356–392. https://doi.org/10.18093/0869-0189-2022-32-3-356-392</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Agustí A., Melén E., DeMeo D.L. et al. Pathogenesis of chronic obstructive pulmonary disease: Understanding the contributions of gene-environment interactions across the lifespan // Lancet Respir. Med. 2022. V. 10. № 5. P. 512–524. doi: 10.1016/S2213-2600(21)00555-5</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Brandsma C.A., Van den Berge M., Hackett T.L. et al. Recent advances in chronic obstructive pulmonary disease pathogenesis: From disease mechanisms to precision medicine // J. Pathol. 2020. V. 250. № 5. P. 624–635. doi: 10.1002/path.5364</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Bridges M.C., Daulagala A.C., Kourtidis A. LNCcation: lncRNA localization and function // J. Cell Biol. 2021. V. 220. № 2. doi: 10.1083/jcb.202009045</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Devadoss D., Long C., Langley R.J. et al. Long noncoding transcriptome in chronic obstructive pulmonary disease // Am. J. Respir. Cell Mol. Biol. 2019. V. 61. № 6. P. 678–688. doi: 10.1165/rcmb.2019-0184TR</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Ward L.D., Kellis M. HaploReg v4: Systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease // Nucl. Acids Res. 2016. V. 44. № D1. P. D877–881. doi: 10.1093/nar/gkv1340</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Korytina G.F., Akhmadishina L.Z., Aznabaeva Y.G. et al. Associations of the NRF2/KEAP1 pathway and antioxidant defense gene polymorphisms with chronic obstructive pulmonary disease // Gene. 2019. V. 692. P. 102–112. doi: 10.1016/j.gene.2018.12.061</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>González J.R., Armengol L., Solé X. et al. SNPassoc: An R package to perform whole genome association studies // Bioinformatics. 2007. V. 23. № 5. P. 644–645. doi: 10.1093/bioinformatics/btm025</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Favorov A.V., Andreewski T.V., Sudomoina M.A. et al. A Markov chain Monte Carlo technique for identification of combinations of allelic variants underlying complex diseases in humans // Genetics. 2005. V. 171. № 4. P. 2113–2121. doi: 10.1534/genetics.105.048090</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Korytina G.F., Akhmadishina L.Z., Markelov V.A. et al. Role of PI3K/AKT/mTOR signaling pathway and sirtuin genes in chronic obstructive pulmonary disease development // Vavil. Zh. Genet. Selektsii. 2023. V. 27. № 5. P. 512–521. doi: 10.18699/VJGB-23-62</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Song Y., Xing H., Zhou L. et al. LncRNA H19 modulated by miR-146b-3p/miR-1539-mediated allelic regulation in transarterial chemoembolization of hepatocellular carcinoma // Arch. Toxicol. 2021. V. 95. № 9. P. 3063–3070. doi: 10.1007/s00204-021-03119-8</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Lu Q., Guo Z., Xie W. et al. The lncRNA H19 mediates pulmonary fibrosis by regulating the miR-196a/COL1A1 Axis // Inflammation. 2018. V. 41. № 3. P. 896–903. doi: 10.1007/s10753-018-0744-4</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Xu J.L., Hua T., Ding J. et al. FOXF2 aggravates the progression of non-small cell lung cancer through targeting lncRNA H19 to downregulate PTEN // Eur. Rev. Med. Pharmacol. Sci. 2019. V. 23. № 24. P. 10796–10802. doi: 10.26355/eurrev_201912_19782</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>15. Wang R., Zhou S., Wu P. et al. Identifying involvement of H19-miR-675-3p-IGF1R and H19-miR-200a-PDCD4 in treating pulmonary hypertension with melatonin // Mol. Ther. Nucl. Acids. 2018. V. 13. P. 44–54. doi: 10.1016/j.omtn.2018.08.015</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Zhang R., Pan T., Xiang Y. et al. Curcumenol triggered ferroptosis in lung cancer cells via lncRNA H19/miR-19b-3p/FTH1 axis // Bioact. Mater. 2021. V. 13. P. 23–36. doi: 10.1016/j.bioactmat.2021.11.013</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Yu H., Qi N., Zhou Q. LncRNA H19 inhibits proliferation and migration of airway smooth muscle cells induced by PDGF-BB through miR-21/PTEN/Akt axis // J. Asthma Allergy. 2021. V. 14. P. 71–80. doi: 10.2147/JAA.S291333</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Bu N., Gao Y., Zhao Y. et al. LncRNA H19 via miR-29a-3p is involved in lung inflammation and pulmonary fibrosis induced by neodymium oxide // Ecotoxicol. Environ. Saf. 2022. V. 247. doi: 10.1016/j.ecoenv.2022.114173</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Liao J., Chen B., Zhu Z. et al. Long noncoding RNA (lncRNA) H19: An essential developmental regulator with expanding roles in cancer, stem cell differentiation, and metabolic diseases // Genes Dis. 2023. V. 10. № 4. P. 1351–1366. doi: 10.1016/j.gendis.2023.02.008</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Li L., Huang Q., Yan F. et al. Association between long non-coding RNA H19 polymorphisms and breast cancer risk: A meta-analysis // Women Health. 2022. V. 62. № 6. P. 565–575. doi: 10.1080/03630242.2022.2096748</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Ghaedi H., Zare A., Omrani M.D. et al. Genetic variants in long noncoding RNA H19 and MEG3 confer risk of type 2 diabetes in an Iranian population // Gene. 2018. V. 675. P. 265–271. doi: 10.1016/j.gene.2018.07.002</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Al-Rugeebah A., Alanazi M., Parine N.R. MEG3: An oncogenic long non-coding RNA in different cancers // Pathol. Oncol. Res. 2019. V. 25. № 3. P. 859–874. doi: 10.1007/s12253-019-00614-3</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Gokey J.J., Snowball J., Sridharan A. et al. MEG3 is increased in idiopathic pulmonary fibrosis and regulates epithelial cell differentiation // JCI Insight. 2018. V. 3. № 17. doi: 10.1172/jci.insight.122490</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Gao X., Li X., Zhang S. et al. The association of MEG3 gene rs7158663 polymorphism with cancer susceptibility // Front. Oncol. 2021. V. 11. doi: 10.3389/fonc.2021.796774.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Li R., Fang L., Pu Q. et al. MEG3-4 is a miRNA decoy that regulates IL-1β abundance to initiate and then limit inflammation to prevent sepsis during lung infection // Sci. Signal. 2018. V. 11. № 536. doi: 10.1126/scisignal.aao2387</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Su Y., Silva J.D., Doherty D. et al. Mesenchymal stromal cells-derived extracellular vesicles reprogramme macrophages in ARDS models through the miR-181a-5p-PTEN-pSTAT5-SOCS1 axis // Thorax. 2023. V. 78. № 6. P. 617–630. doi: 10.1136/thoraxjnl-2021-218194</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Chen L., Xie W., Wang L. et al. MiRNA-133a aggravates inflammatory responses in sepsis by targeting SIRT1 // Int. Immunopharmacol. 2020. V. 88. doi: 10.1016/j.intimp.2020.106848</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Green C.E., Clarke J., Bicknell R. et al. Pulmonary microRNA changes alter angiogenesis in chronic obstructive pulmonary disease and lung cancer // Biomedicines. 2021. V. 9. № 7. doi: 10.3390/biomedicines9070830</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Wu H., Ma H., Wang L. et al. Regulation of lung epithelial cell senescence in smoking-induced COPD/emphysema by microR-125a-5p via Sp1 mediation of SIRT1/HIF-1a // Int. J. Biol. Sci. 2022. V. 18. № 2. P. 661–674. doi: 10.7150/ijbs.65861</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Zhong S., Chen C., Liu N. et al. Overexpression of hsa-miR-664a-3p Is associated with cigarette smoke-induced chronic obstructive pulmonary disease via targeting FHL1 // Int. J. Chron. Obstruct. Pulmon. Dis. 2019. V. 14. P. 2319–2329. doi: 10.2147/COPD.S224763</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Guil S., Soler M., Portela A. et al. Intronic RNAs mediate EZH2 regulation of epigenetic targets // Nat. Struct. Mol. Biol. 2012. V. 19. № 7. P. 664–670. doi: 10.1038/nsmb.2315</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Holdt L.M., Teupser D. Long noncoding RNA ANRIL: Lnc-ing genetic variation at the chromosome 9p21 locus to molecular mechanisms of atherosclerosis // Front. Cardiovasc. Med. 2018. V. 5. doi: 10.3389/fcvm.2018.00145</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Van der Harst P., Verweij N. Identification of 64 novel genetic loci provides an expanded view on the genetic architecture of coronary artery disease // Circ. Res. 2018. V. 122. № 3. P. 433–443. doi: 10.1161/CIRCRESAHA.117.312086</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Cunnington M.S., Santibanez Koref M., Mayosi B.M. et al. Chromosome 9p21 SNPs associated with multiple disease phenotypes correlate with ANRIL expression // PLoS Genet. 2010. V. 6. № 4. doi: 10.1371/journal.pgen.1000899</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Ge J., Geng S., Jiang H. Long noncoding RNAs antisense noncoding RNA in the INK4 locus (ANRIL) correlates with lower acute exacerbation risk, decreased inflammatory cytokines, and mild GOLD stage in patients with chronic obstructive pulmonary disease // J. Clin. Lab. Anal. 2019. V. 33. № 2. doi: 10.1002/jcla.22678</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Deelen J., Beekman M., Uh H.W. et al. Genome-wide association meta-analysis of human longevity identifies a novel locus conferring survival beyond 90 years of age // Hum. Mol. Genet., 2014. V. 23. № 16. P. 4420–4432. doi: 10.1093/hmg/ddu139</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Sun W., Liu C., Chen Q. et al. SIRT3: A new regulator of cardiovascular diseases // Oxid. Med. Cell Longev. 2018. V. 2018. doi: 10.1155/2018/7293861</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Zhang D.D., Wang W.T., Xiong J. et al. Long noncoding RNA LINC00305 promotes inflammation by activating the AHRR-NF-κB pathway in human monocytes // Sci. Rep. 2017. V. 7. doi: 10.1038/srep46204</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Wahba A.S., Ibrahim M.E., Mesbah N.M. et al. Serum LINC00305 expression and its genetic variant rs2850711 are associated with clinical and laboratory features of rheumatoid arthritis // Br. J. Biomed. Sci. 2020. V. 77. № 3. P. 142–147. doi: 10.1080/09674845.2020.1744942</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Manning A.K., Hivert M.F., Scott R.A. et al. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance // Nat. Genet. 2012. V. 44. № 6. P. 659–669. doi: 10.1038/ng.2274</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Johnson M.E., Schug J., Wells A.D. et al. Genome-wide analyses of ChIP-Seq derived FOXA2 DNA occupancy in liver points to genetic networks underpinning multiple complex traits // J. Clin. Endocrinol. Metab. 2014. V. 99. № 8. P.E1580-5. doi: 10.1210/jc.2013-4503</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Chen Z., Xiang L., Li L. et al. TGF-β1 induced deficiency of linc00261 promotes epithelial-mesenchymal-transition and stemness of hepatocellular carcinoma via modulating SMAD3 // J. Transl. Med. 2022. V. 20. № 1. P.75. doi: 10.1186/s12967-022-03276-z</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Zhu R., Liu X., He Z. Long non-coding RNA H19 and MALAT1 gene variants in patients with ischemic stroke in a northern Chinese Han population // Mol. Brain. 2018. V. 11. № 1. P. 58. doi: 10.1186/s13041-018-0402-7</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Chen M., Cai D., Gu H. et al. MALAT1 rs619586 A/G polymorphisms are associated with decreased risk of lung cancer // Medicine (Baltimore). 2021. V. 100. № 12. doi: 10.1097/MD.0000000000023716</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Wu W., Wang S., Zhang L. et al. Mechanistic studies of MALAT1 in respiratory diseases // Front. Mol. Biosci. 2022. V. 9. doi: 10.3389/fmolb.2022.1031861</mixed-citation></ref></ref-list></back></article>
